Share
Recent trends in drug development, rising cost pressures, and evolving regulatory changes are highlighting the critical need for tech-driven supply chain solutions in the life sciences industry. Union Square's Sector Spotlight delves into how advanced technologies are helping companies navigate these challenges efficiently, ensuring compliance and cost-effectiveness.
Rob Larson and Jordan Abrams from Stax contributed to the report, which outlines how tech-powered supply chain solutions may aid in shortening drug development time frames, increase efficiency and savings, and focus on innovation. The report outlines trends defining the market, including the globalization of the value chain, increased complexity, and a growing prevalence in cancer spurring further growth in oncology.
Compiled together with various thought leaders from both Stax and Union Square Advisors, this report offers insight for any investors seeking a perspective on the trajectory of supply chain technology—including a view of the market and what companies to watch.
Read More
